Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Drug 'helps reduce blood sugar'

  • Comment

A new drug lowers blood sugar in patients with type-2 diabetes, according to a new study.

Researchers found Dapagliflozin prevented the reabsorption of glucose by the kidneys and increased the amount of sugar released in the urine.

The drug, which works independently of insulin, could help those who have inadequate blood sugar control with first line drug metformin, the study found.

Researchers believe it could also help those with early and late stage diabetes.

The findings are reported in an article in this week’s American Diabetes Association meeting Special Issue of The Lancet, written by Professor Clifford Bailey, Aston University, Birmingham, UK, and colleagues.

Since many complications of diabetes are related to high concentrations of blood glucose, directly lowering blood glucose is a legitimate target for new drugs for diabetes.

In this study, the authors assessed the efficacy and safety of dapagliflozin in patients not managing to control their blood sugar with the first-line treatment of metformin.

The phase 3 randomised controlled trial assessed 546 adult patients with diabetes, who were receiving daily metformin, yet had inadequate blood sugar control.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs